Skip to search formSkip to main contentSkip to account menu

oral anticoagulants

Known as: anticoagulant oral, anticoagulants oral, oral anticoagulant 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2017
Highly Cited
2017
Objective To examine clinical effectiveness and safety of apixaban 2.5 mg, dabigatran 110 mg, and rivaroxaban 15 mg compared with… 
Highly Cited
2017
Highly Cited
2017
Aim The aim of this study is to examine temporal trends in the use oral anticoagulants (OAC) as stroke prophylaxis in patients… 
Review
2016
Review
2016
Summary Oral anticoagulation is pivotal in the management of thromboembolic risk in non-valvular atrial fibrillation (NVAF… 
Review
2015
Review
2015
Direct oral anticoagulants (DOACs) are widely used as an alternative for warfarin. However, the impact of DOACs on mortality… 
Highly Cited
2015
Highly Cited
2015
Objectives To determine the real world safety of dabigatran or rivaroxaban compared with warfarin in terms of gastrointestinal… 
Review
2014
Review
2014
To evaluate the efficacy and safety of new oral anticoagulants (NOACs) in elderly adults. 
Review
2005
Review
2005
Context Although many outpatients require oral anticoagulation, the optimal management of outpatient anticoagulation remains… 
Review
1992
Review
1992
Amiodarone, originally developed over 20 years ago, is a potent antiarrhythmic drug with the actions of all antiarrhythmic drug…